Curaleaf (OTCMKTS:CURLF) Sets New 12-Month High – Here’s Why

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s share price reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $10.40 and last traded at $9.50, with a volume of 137328 shares. The stock had previously closed at $3.41.

Wall Street Analysts Forecast Growth

Separately, Zacks Research downgraded shares of Curaleaf from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 3rd. Two investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Hold rating to the company. According to MarketBeat, Curaleaf presently has an average rating of “Buy”.

Curaleaf Price Performance

The company has a market capitalization of $6.64 billion, a price-to-earnings ratio of -73.08 and a beta of 1.53. The company has a fifty day simple moving average of $7.65 and a two-hundred day simple moving average of $7.55. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.74 and a current ratio of 1.56.

Curaleaf (OTCMKTS:CURLF) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.24) by $0.51. The business had revenue of $324.23 million for the quarter, compared to analysts’ expectations of $316.62 million. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%. As a group, research analysts anticipate that Curaleaf Holdings, Inc. will post -0.1 earnings per share for the current year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.